Fish Vaccine Market Scope And Analysis

Report Code : TIPRE00020208
Category : Life Sciences

Status : Published
No. of Pages : 180

Buy Now

Fish Vaccine Market Analysis Report 2023 to 2030

Buy Now

Fish Vaccine Market Report Scope

Report Attribute	Details
Market size in 2022	US$ 355.88 Million
Market Size by 2030	US$ 617.38 Million
Global CAGR (2022 - 2030)	7.1%
Historical Data	2020-2021
Forecast period	2023-2030
Segments Covered	By Vaccine Type Inactivated Vaccines Live Vaccines Subunit Vaccines Recombinant Vector Vaccine By Application Bacterial Viral Parasitic By Route of Administration Injected Immersion Oral By Species Salmon Trout Tilapia
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Zoetis Inc Merck Co Inc Hipra SA Phibro Animal Health Corp Vaxxinova International BV Kyoto Biken Laboratories Elanco Animal Health Inc Nisseiken Co Ltd KBNP Inc

Competitive Landscape and Key Companies:

Zoetis Inc., Merck & Co Inc., Hipra SA, Phibro Animal Health Corp, Vaxxinova International BV, Kyoto Biken Laboratories, Elanco Animal Health Inc., Nisseiken Co., Ltd., KBNP Inc., Choong Ang Vaccine Laboratories Co., Ltd., and INDIAN IMMUNOLOGICALS LTD. are a few prominent players operating in the fish vaccine market. These companies focus on expanding service offerings to meet the growing consumer demand worldwide. Their global presence allows them to serve a large set of customers, subsequently allowing them to expand their market share.